ICUI - ICU Medical, Inc.

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Currency in USD

Valuation Measures

Market Cap (intraday) 5
3.69B
Enterprise Value 3
3.31B
Trailing P/E
52.67
Forward P/E 1
24.61
PEG Ratio (5 yr expected) 1
1.35
Price/Sales (ttm)
2.86
Price/Book (mrq)
2.75
Enterprise Value/Revenue 3
2.56
Enterprise Value/EBITDA 6
14.46

Trading Information

Stock Price History

Beta (3Y Monthly) 0.90
52-Week Change 3-26.08%
S&P500 52-Week Change 315.97%
52 Week High 3259.72
52 Week Low 3148.89
50-Day Moving Average 3160.89
200-Day Moving Average 3199.68

Share Statistics

Avg Vol (3 month) 3220.89k
Avg Vol (10 day) 3350.4k
Shares Outstanding 520.67M
Float 19.2M
% Held by Insiders 17.13%
% Held by Institutions 193.55%
Shares Short (Oct 31, 2019) 4993.77k
Short Ratio (Oct 31, 2019) 45.78
Short % of Float (Oct 31, 2019) 47.25%
Short % of Shares Outstanding (Oct 31, 2019) 44.81%
Shares Short (prior month Sep 30, 2019) 4763.23k

Dividends & Splits

Forward Annual Dividend Rate 4N/A
Forward Annual Dividend Yield 4N/A
Trailing Annual Dividend Rate 3N/A
Trailing Annual Dividend Yield 3N/A
5 Year Average Dividend Yield 4N/A
Payout Ratio 40.00%
Dividend Date 3N/A
Ex-Dividend Date 4N/A
Last Split Factor (new per old) 22/3
Last Split Date 3Mar 18, 2002

Financial Highlights

Fiscal Year

Fiscal Year Ends Dec 31, 2018
Most Recent Quarter (mrq)Sep 30, 2019

Profitability

Profit Margin 5.66%
Operating Margin (ttm)11.76%

Management Effectiveness

Return on Assets (ttm)5.96%
Return on Equity (ttm)5.62%

Income Statement

Revenue (ttm)1.29B
Revenue Per Share (ttm)62.74
Quarterly Revenue Growth (yoy)-6.00%
Gross Profit (ttm)570.03M
EBITDA 228.5M
Net Income Avi to Common (ttm)73.04M
Diluted EPS (ttm)3.39
Quarterly Earnings Growth (yoy)12,029.20%

Balance Sheet

Total Cash (mrq)338.1M
Total Cash Per Share (mrq)16.35
Total Debt (mrq)36.94M
Total Debt/Equity (mrq)2.76
Current Ratio (mrq)3.70
Book Value Per Share (mrq)64.84

Cash Flow Statement

Operating Cash Flow (ttm)102.99M
Levered Free Cash Flow (ttm)96.28M